Renaissance Technologies’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,611
| Closed | -$34.2K | – | 3526 |
|
|
2024
Q4 | $34.2K | Buy |
+10,611
| New | +$34.2K | ﹤0.01% | 3432 |
|
|
2023
Q2 | – | Sell |
-4,335
| Closed | -$38K | – | 3984 |
|
|
2023
Q1 | $38K | Sell |
4,335
-4,844
| -53% | -$42.5K | ﹤0.01% | 3713 |
|
|
2022
Q4 | $120K | Sell |
9,179
-4,990
| -35% | -$65.2K | ﹤0.01% | 3562 |
|
|
2022
Q3 | $244K | Sell |
14,169
-8,635
| -38% | -$149K | ﹤0.01% | 3296 |
|
|
2022
Q2 | $250K | Buy |
22,804
+7,676
| +51% | +$84.2K | ﹤0.01% | 3550 |
|
|
2022
Q1 | $336K | Sell |
15,128
-2,167
| -13% | -$48.1K | ﹤0.01% | 3417 |
|
|
2021
Q4 | $595K | Buy |
17,295
+13,680
| +378% | +$471K | ﹤0.01% | 2993 |
|
|
2021
Q3 | $222K | Sell |
3,615
-10,622
| -75% | -$652K | ﹤0.01% | 3170 |
|
|
2021
Q2 | $1.11M | Buy |
14,237
+2,577
| +22% | +$201K | ﹤0.01% | 2622 |
|
|
2021
Q1 | $651K | Buy |
11,660
+10,765
| +1,203% | +$601K | ﹤0.01% | 2804 |
|
|
2020
Q4 | $55K | Buy |
+895
| New | +$55K | ﹤0.01% | 3312 |
|
|
2020
Q3 | – | Sell |
-4,250
| Closed | -$502K | – | 3423 |
|
|
2020
Q2 | $502K | Buy |
4,250
+1,460
| +52% | +$172K | ﹤0.01% | 2874 |
|
|
2020
Q1 | $148K | Buy |
+2,790
| New | +$148K | ﹤0.01% | 3160 |
|